Patient Seminar Program
![](/media/2017/10/1_img_8487.jpg)
Co chairs, Ate van der Zee, Immediate Past President, ESGO & Louise Bayne, CEO Ovacome UK, opening the ESGO Patient Seminar
![](/media/2017/10/2_img_8532.jpg)
Ate van der Zee, Immediate Past President, ESGO introducing gynaecological cancers.
![](/media/2017/10/3_img_8534_rev.jpg)
John Butler, International Cancer Benchmarking Partnership, Gynaecological Oncology Fellow St Bartholomews and Royal Marsden Hospital, UK talking about the inequalities in survival of gynaecological cancers in Europe today.
![](/media/2017/10/4_img_8539-1.jpg)
Ate van der Zee, Immediate Past President, ESGO talking to ESGO Patient Seminar participants.
![](/media/2017/10/5_img_8541.jpg)
From left to right : Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO ; Louise Bayne, CEO, Ovacome UK and Jan Geissler, CEO Patvocates and Co-Founder CML Advocates Network.
![](/media/2017/10/6_img_8543.jpg)
ESGO Patient Seminar Participants enjoying a coffee break.
![](/media/2017/10/7_img_8563.jpg)
Session speakers during the Q & A. From left to right: Flavia Bideri, ACTO onlus, Italy (Patient Participation in Research) ; Jalid Sehouli, Charité Universitätsmedizin Berlin, Germany (Current options and the ongoing future of clinical trials) ; Emma Elliot, National Forum of Gynaecological Oncology Nurses, UK (Multidisciplinary treatment in gynaecological cancer) and Frederic Amant, UZ Gasthuisberg/Katholieke Universiteit Leuven, Belgium (Innovation, target therapies and individualised medicine)
![](/media/2017/10/8_img_8602.jpg)
Louise Bayne, CEO Ovacome, UK, speaking about their leading initiatives in Ovarian cancer.
![](/media/2017/10/9_img_8614.jpg)
Doris Schmitt, PATH, Germany presenting the Patient-driven breast cancer tumour bank as a possible model for gynaecological cancers.